60 Degrees Pharmaceuticals, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
60 Degrees Pharmaceuticals, Inc. has filed an S-1 registration statement for a public offering of common stock and warrants to raise approximately $4.2 million, while its auditors have raised substantial doubt about its ability to continue as a going concern.
NASDAQ
S-1/A: 60 Degrees Pharmaceuticals Files Amendment to S-1 Registration for Potential Resale of Common Stock
60 Degrees Pharmaceuticals has filed an amendment to its S-1 registration statement, covering the potential resale of up to 747,200 shares of common stock by selling stockholders, derived from the exercise of warrants.
NASDAQ
60 Degrees Pharmaceuticals is registering for the resale of up to 3,735,977 shares of its common stock by selling stockholders, derived from warrant exercises.
NASDAQ
S-1: 60 Degrees Pharmaceuticals Files for Unit Offering to Fund Malaria and Tick-Borne Disease Programs
60 Degrees Pharmaceuticals is seeking to raise capital through a unit offering to support its malaria prevention product and expand into new therapeutic areas like tick-borne diseases.